Use ICD-10 code G71.036 for patients with LGMD2I/R9

Time is muscle

Limb-girdle muscular dystrophy (LGMD) is a group of genetic neuromuscular disorders that cause progressive muscle weakness, predominantly affecting the upper arms and legs ("limb") and the thoracic ("girdle") muscles.1,2

Genetic testing is essential to confirming subtype, guiding care, opening the door to treatment opportunities, and helping monitor potential complications.3-5

Learn About Genetic Testing
Stafford, person living with LGMD2I/R9 standing outdoors with a walking aid
Dan, Jameson, and Melissa, individuals living with LGMD2I/R9

LGMD affects more than strength4

LGMD includes 30+ subtypes with varying progression and systemic impact. Identifying the specific type, such as FKRP-related limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9), is key to understanding the disease.1,3,4

What Sets LGMD2I/R9 Apart

LGMD2I/R9 MAY BE misdiagnosed3,6,7

Delays in diagnosis are common, which can impact care. Recognizing early signs helps guide appropriate next steps3,6

Know When & How to Test

Signs and symptoms of LGMD2I/R9

Symptoms often develop gradually, affecting mobility, strength, and respiratory or cardiac function. Early recognition helps guide management.3,4

How LGMD2I/R9 is Managed
Type Hype

Know your type.
Find your people.

In LGMD, knowing your subtype can help connect you to expert care, relevant resources, and a community of people who understand what you're going through.8
This is Type Hype
Learn About Genetic Testing